EMILY LOPEZ: Open Payments
NPI 1487918876 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 59 payments from 20 companies in 2025. Trend: 2023 $1,369 · 2024 $1,846 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $279 |
| Lilly USA, LLC | 10 | $154 |
| Phathom Pharmaceuticals, Inc. | 5 | $73 |
| PFIZER INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Amgen Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
Products named: Wegovy, MOUNJARO, VOQUEZNA, CAPLYTA, LEQVIO, ELIQUIS, OTEZLA, Ozempic.
Industry payments across KY — which companies pay providers there.
